Development and Supply of a Dedicated Diagnostics Iinstrument – Agreement building upon established OEM partnership between both companies – Concept development and feasibility testing already successfully completed – Tecan signed a ten-year supply agreement with a purchase commitment by the diagnostic company – Upon successful completion of development, based on Tecan’s expectations sales potential is […]

Addition of high-growth business accelerates expansion into molecular diagnostics -Conference call to be held on December 6, 2010- OMAHA, Neb. – Transgenomic, Inc. (OTCBB: TBIO) announced today the signing of a definitive agreement for Transgenomic to acquire the diagnostic business of Clinical Data, Inc. (Nasdaq GM:CLDA). This acquisition includes a suite of proprietary genetic commercial […]

Hepachronix project will pool expertise to develop and market an in vitro diagnostic kit for chronic, viral hepatitis Paris, France – Ariana(R) Pharma, a leader in decision support tools and services to accelerate the development and optimal use of drugs and biomarker discovery, announces today that it has entered into a partnership to improve the […]

xTAG® CYP2D6 Kit Can Assist Physicians in Improving Patient Care by Helping to Determine a Personalized Therapeutic Strategy AUSTIN, Texas – Luminex Corporation (Nasdaq: LMNX), today announced that it has commercially launched its first pharmacogenetic test, the xTAG® CYP2D6 Kit, which recently received 510(k) clearance from the U.S. Food and Drug Administration (FDA). The new […]